Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 11 years
- Director since
- 2023
11 years of board service in total across 4 boards, counting each seat separately. Longest: Olema Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
UroGen Pharma Ltd. June 22, 202693.2%
-
UroGen Pharma Ltd. August 26, 202598.6%
-
Olema Pharmaceuticals Inc. June 10, 202579.2%
-
UroGen Pharma Ltd. August 6, 202497.4%
-
UroGen Pharma Ltd. September 7, 202398.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 26, 2025 | UroGen Pharma Ltd. | Option exercise | +2,000 | — | — |
Questions about Cynthia M. Butitta
What boards is Cynthia M. Butitta on?
Cynthia M. Butitta sits on the boards of Autolus Therapeutics plc American Depositary Share, Century Therapeutics Inc., Olema Pharmaceuticals Inc. and UroGen Pharma Ltd.
How long has Cynthia M. Butitta served on boards?
Our records show at least 11 years of board service across 4 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.